US 10227610
Methods and compositions for enhancing nuclease-mediated gene disruption
granted A61KA61K31/502A61K31/5377
Quick answer
US patent 10227610 (Methods and compositions for enhancing nuclease-mediated gene disruption) held by Sangamo Therapeutics, Inc. expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/502, A61K31/5377, A61P, A61P43/00